MarginsXMarginsX
Home › Markets › Health Care › HYFT

MindWalk Holdings Corp. (HYFT)

HYFT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9378
-8.95% on the day
Market cap
$44.6M
Nano cap
Revenue · 2026
$10.9M
-36.5% on 2025
Net income · 2026
-$9.8M
-89.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2026-04-30, https://www.sec.gov/Archives/edgar/data/1715925/000119312526312694/0001193125-26-312694-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2026-04-30. Converted from CAD at 1.4258 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerHYFT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001715925
SEC industry codePharmaceutical Preparations
Incorporated inBC

Financials · 2026

LineValue
Revenue$10.9M
Net income-$9.8M
Operating incomeNot in SEC XBRL data
Net margin-89.7%
Operating marginOperating income not reported
Revenue growth-36.5%
Cash$8.0M
Total assets$15.0M
P/E (computed)Net income was not positive
P/S (computed)4.1×

Reported in CAD; shown in US dollars.

Warning signs

Cash runway
11.0 months
11.5M CAD cash at April 30, 2026
Share count, 1 year
+1.2%
2025-04-30 to 2026-04-30 · +86.5% over 3 years
Going-concern doubt
Yes
20-F filed July 23, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions, along with other matters as set forth in Note 1, raise substantial doubt about the Company's ability to continue as a going concern."
20-F 2026-07-23
Cash and burn11.5M CAD cash; operating cash flow -3.1M CAD a quarter.Report 2026-04-30
Shares outstanding46,711,866 (2026-04-30); 46,154,118 a year earlier; 25,050,260 three years earlier. the newest SEC cover-page count is from 2026-04-30; shares issued since then are not in these figures.Cover page 2026-04-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-07-13
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDavidson & Company LLP, Vancouver, CanadaPCAOB Form AP 2026-08-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-04-30
15.6M CAD-13.9M CAD-12.5M CAD11.5M CADNo debt tags15.6M CAD20-F 2026-07-23
FY 2025
2025-04-30
24.5M CAD-30.2M CAD-6.4M CAD10.8M CADNo debt tags24.5M CAD20-F 2025-07-29
FY 2024
2024-04-30
24.5M CAD-26.1M CAD-3.2M CAD3.5M CADNo debt tags24.5M CAD20-F 2025-07-29
FY 2023
2023-04-30
20.7M CAD-26.6M CAD-19.8M CAD8.4M CADNo debt tags20.7M CAD20-F 2025-07-29
FY 2022
2022-04-30
19.4M CAD-16.7M CAD-9.9M CAD30.0M CADNo debt tags19.4M CAD20-F 2024-07-29
FY 2021
2021-04-30
17.9M CAD-7.3M CAD-600K CAD41.8M CADNo debt tags17.9M CAD40-F 2022-07-29
FY 2020
2020-04-30
14.1M CAD-4.9M CAD-1.4M CAD2.7M CAD312K CAD14.1M CAD40-F/A 2021-09-29

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentF-32026-07-13
Latest annual report20-F2026-07-23
Latest quarterly / interim6-K2026-11-04

Source: SEC EDGAR submissions feed, 287 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.6%
1 month-33.1%
3 months-28.8%
Year to date-45.6%
1 year-40.0%
From 52-week high-64.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ONCYOncolytics Biotech Inc.$0.3399-8.14%$44.6M
TLPHTalphera Inc.$0.8609-4.98%$44.7M
NMADNomad Power Solutions Inc.$2.80+19.15%$45.1M
MISTMilestone Pharmaceuticals Inc. Common Shares$0.3650-29.81%$45.4M
RNXTRenovoRx Inc.$0.9549-8.18%$46.1M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M
ANVSAnnovis Bio Inc.$0.7500-19.02%$46.5M
ATNMActinium Pharmaceuticals Inc. (Delaware)$1.49-9.15%$46.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier